Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors

BACKGROUND/AIMS: Teicoplanin can be used as an alternative to vancomycin when treating beta-lactam-resistant gram-positive bacterial infections. Both vancomycin and teicoplanin are associated with relatively high rates of adverse drug reactions (ADRs), including hypersensitivity reactions. There is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Byung-Keun, Kim, Jung-Hyun, Sohn, Kyoung-Hee, Kim, Ju-Young, Chang, Yoon-Seok, Kim, Sae-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214367/
https://www.ncbi.nlm.nih.gov/pubmed/31722513
http://dx.doi.org/10.3904/kjim.2018.404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214367/
https://www.ncbi.nlm.nih.gov/pubmed/31722513
http://dx.doi.org/10.3904/kjim.2018.404

Ejemplares similares